These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb. Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161 [TBL] [Abstract][Full Text] [Related]
7. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils. Tam SW; Demissie S; Thomas D; Daëron M Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766 [TBL] [Abstract][Full Text] [Related]
9. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. Williams CM; Galli SJ J Allergy Clin Immunol; 2000 May; 105(5):847-59. PubMed ID: 10808163 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of autoimmune activation of basophils in chronic urticaria. Kikuchi Y; Kaplan AP J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptide regulation of the expression of immediate hypersensitivity. Goetzl EJ; Chernov T; Renold F; Payan DG J Immunol; 1985 Aug; 135(2 Suppl):802s-805s. PubMed ID: 2409168 [TBL] [Abstract][Full Text] [Related]
12. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. Christensen LH; Holm J; Lund G; Riise E; Lund K J Allergy Clin Immunol; 2008 Aug; 122(2):298-304. PubMed ID: 18572230 [TBL] [Abstract][Full Text] [Related]
13. Association between reduced levels of total serum IgE and FcepsilonRI expression in non-releaser basophils. Kumar P; Singh B; Lal R; Rembhotkar GW; Singh AB Immunobiology; 2009; 214(5):377-83. PubMed ID: 19362683 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of urticaria. Keahey TM Dermatol Clin; 1985 Jan; 3(1):13-28. PubMed ID: 3937649 [TBL] [Abstract][Full Text] [Related]
15. Attainments in atop: special aspects of allergy and IgE. Milgrom H Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775 [TBL] [Abstract][Full Text] [Related]
16. Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation. Crivellato E; Travan L; Ribatti D Int Arch Allergy Immunol; 2010; 151(2):89-97. PubMed ID: 19752562 [TBL] [Abstract][Full Text] [Related]
17. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? Ott VL; Cambier JC J Allergy Clin Immunol; 2000 Sep; 106(3):429-40. PubMed ID: 10984360 [TBL] [Abstract][Full Text] [Related]
18. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Asero R; Lorini M; Chong SU; Zuberbier T; Tedeschi A Clin Exp Allergy; 2004 Jul; 34(7):1111-4. PubMed ID: 15248858 [TBL] [Abstract][Full Text] [Related]
19. [Immunological and non immunological mechanisms in urticaria]. Bérard F; Saint-Mezard P; Cousin F; Mecheri S; Nicolas JF Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S10-5. PubMed ID: 12843804 [TBL] [Abstract][Full Text] [Related]
20. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]